The buy now/pay later lender outperformed nearly every analyst estimate in its fiscal Q2 2025 earnings report. CEO Max Levchin said the company is 5 months out from positive GAAP operating income.
JMP Securities reiterated its Market Outperform rating and $78.00 price target for Cytokinetics shares (NASDAQ:CYTK). This affirmation comes despite the stock experiencing a significant drop on ...
The U.S. Army’s Joint Program Executive Office for Armaments and Ammunition, along with the Joint Munitions Command, ...
1d
As well as being essential in the precise packaging of DNA into the space of the nucleus, histone proteins are also the site ...
Program bridges engineering expertise with leadership skills to meet industry demand. Alvernia University launches a fully ...
Hell hath no fury like an athletic prospect scorned. Nebraska football has learned this the hard way over the years, turning ...
The School of Computer Science and Statistics (SCSS) ranks 1st in Ireland, a leading School in Europe and in the top 100 universities in the world according to the QS World University Subject Rankings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback